SER Serina Therapeutics, Inc.
$1.67▼ -2.34%
Healthcare
Other
Volume 172.0K
Avg Volume (10D) 31.7K
Key Metrics & Fundamentals
Market Cap
$42.42M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.22 - 5.09
% vs 50 MA
-24.07%
% vs 200 MA
-20.50%
RSI-14
36.0
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.58
Free Cash Flow
-$6.71M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$6.19M
COGS
–
Operating Exp
$6.78M
Operating Income
-$6.78M
EBIT
-$6.78M
Pretax Income
-$6.36M
Net Income
-$6.36M
EPS (Diluted)
-0.55
Price & Volume History
Loading chart…
Recent News
Registration Is Now Open For Tribe Public’s CEO Presentation and Q&A Webinar Event "A New Approach to Advanced Parkinson’s Disease: Serina Discusses SER-252’s Clinical Progress"
GlobeNewswire · Sep 23, 2026 4:18 PM ET
Serina Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 10, 2026 4:05 PM ET
Serina Therapeutics Reports Cohort 1 Observations from SER-252 Registrational Study in Advanced Parkinson’s Disease and Advances to Cohort 2
GlobeNewswire · Sep 9, 2026 7:45 AM ET
Serina Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
GlobeNewswire · Aug 13, 2026 4:15 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See SER's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.